Bayer AG, founded in 1863 and headquartered in Leverkusen, Germany, is a global enterprise with core competencies in the life science fields of healthcare and agriculture. The company's operations are divided into three main segments: Pharmaceuticals, focusing on prescription products primarily for cardiology and women's healthcare; Consumer Health, offering over-the-counter medications and health products; and Crop Science, providing innovative solutions for seeds, crop protection, and pest control. Bayer is committed to sustainability and innovation, aiming to improve the quality of life by preventing, alleviating, and treating diseases, as well as ensuring a reliable food supply. With a presence in over 90 countries, Bayer employs approximately 100,000 people worldwide, dedicated to advancing health and nutrition.
Pheromone gel technology expands to Asia-Pacific, Latin America, and U.S., offering sustainable, low-residue crop protection with reduced plastic waste.
Bayer & partners will scale winter canola as a renewable fuel feedstock, with an aim to launch hybrid TruFlex canola by 2027 to decarbonize transportation with sustainable fuels.
The agreement focuses on Digital Farming, ForwardFarming, Capacity Building, and Seed Trials, advancing UAE's agricultural innovation and sustainability goals.
Genvor will receive year-long access to lab space and equipment at Bayer’s LifeHub California @AgStart, one of the premier U.S. AgriFoodTech innovation ecosystems.
Promoting and scaling regenerative agricultural practices are key to producing more while restoring nature – with R&D and digital technologies being key enablers.